Astrana Health Statistics
Total Valuation
Astrana Health has a market cap or net worth of $1.75 billion. The enterprise value is $1.88 billion.
| Market Cap | 1.75B |
| Enterprise Value | 1.88B |
Important Dates
The next confirmed earnings date is Thursday, February 27, 2025, after market close.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Astrana Health has 49.12 million shares outstanding. The number of shares has increased by 3.20% in one year.
| Current Share Class | 49.12M |
| Shares Outstanding | 49.12M |
| Shares Change (YoY) | +3.20% |
| Shares Change (QoQ) | +0.51% |
| Owned by Insiders (%) | 12.82% |
| Owned by Institutions (%) | 51.93% |
| Float | 36.62M |
Valuation Ratios
The trailing PE ratio is 27.42 and the forward PE ratio is 29.33. Astrana Health's PEG ratio is 1.59.
| PE Ratio | 27.42 |
| Forward PE | 29.33 |
| PS Ratio | 0.98 |
| Forward PS | 0.67 |
| PB Ratio | 2.42 |
| P/TBV Ratio | 9.43 |
| P/FCF Ratio | 25.08 |
| P/OCF Ratio | 21.26 |
| PEG Ratio | 1.59 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.16, with an EV/FCF ratio of 26.87.
| EV / Earnings | 30.07 |
| EV / Sales | 1.09 |
| EV / EBITDA | 17.16 |
| EV / EBIT | 22.16 |
| EV / FCF | 26.87 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.94.
| Current Ratio | 1.91 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.94 |
| Debt / EBITDA | 3.95 |
| Debt / FCF | 6.81 |
| Interest Coverage | 2.78 |
Financial Efficiency
Return on equity (ROE) is 10.26% and return on invested capital (ROIC) is 5.78%.
| Return on Equity (ROE) | 10.26% |
| Return on Assets (ROA) | 4.49% |
| Return on Invested Capital (ROIC) | 5.78% |
| Return on Capital Employed (ROCE) | 8.72% |
| Revenue Per Employee | $956,871 |
| Profits Per Employee | $34,698 |
| Employee Count | 1,800 |
| Asset Turnover | 1.46 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Astrana Health has paid $26.02 million in taxes.
| Income Tax | 26.02M |
| Effective Tax Rate | 31.11% |
Stock Price Statistics
The stock price has decreased by -9.12% in the last 52 weeks. The beta is 1.21, so Astrana Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.21 |
| 52-Week Price Change | -9.12% |
| 50-Day Moving Average | 35.51 |
| 200-Day Moving Average | 44.57 |
| Relative Strength Index (RSI) | 43.50 |
| Average Volume (20 Days) | 263,852 |
Short Selling Information
The latest short interest is 1.68 million, so 3.41% of the outstanding shares have been sold short.
| Short Interest | 1.68M |
| Short Previous Month | 1.60M |
| Short % of Shares Out | 3.41% |
| Short % of Float | 4.58% |
| Short Ratio (days to cover) | 4.32 |
Income Statement
In the last 12 months, Astrana Health had revenue of $1.72 billion and earned $62.46 million in profits. Earnings per share was $1.30.
| Revenue | 1.72B |
| Gross Profit | 259.89M |
| Operating Income | 84.76M |
| Pretax Income | 96.65M |
| Net Income | 62.46M |
| EBITDA | 109.46M |
| EBIT | 84.76M |
| Earnings Per Share (EPS) | $1.30 |
Balance Sheet
The company has $350.35 million in cash and $475.97 million in debt, giving a net cash position of -$125.63 million or -$2.56 per share.
| Cash & Cash Equivalents | 350.35M |
| Total Debt | 475.97M |
| Net Cash | -125.63M |
| Net Cash Per Share | -$2.56 |
| Equity (Book Value) | 507.11M |
| Book Value Per Share | 14.75 |
| Working Capital | 284.06M |
Cash Flow
In the last 12 months, operating cash flow was $82.45 million and capital expenditures -$12.56 million, giving a free cash flow of $69.89 million.
| Operating Cash Flow | 82.45M |
| Capital Expenditures | -12.56M |
| Free Cash Flow | 69.89M |
| FCF Per Share | $1.42 |
Margins
Gross margin is 15.09%, with operating and profit margins of 4.92% and 3.63%.
| Gross Margin | 15.09% |
| Operating Margin | 4.92% |
| Pretax Margin | 4.86% |
| Profit Margin | 3.63% |
| EBITDA Margin | 6.36% |
| EBIT Margin | 4.92% |
| FCF Margin | 4.06% |
Dividends & Yields
Astrana Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.20% |
| Shareholder Yield | -3.20% |
| Earnings Yield | 3.56% |
| FCF Yield | 3.99% |
Analyst Forecast
The average price target for Astrana Health is $65.60, which is 83.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $65.60 |
| Price Target Difference | 83.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 20.37% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Astrana Health has an Altman Z-Score of 3.61 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.61 |
| Piotroski F-Score | 5 |